Who replaces Renaudin and what roles are changing?

Aaron Martin joins in January 2026 as President of Medicare Advantage and, after Renaudin's transition, becomes Insurance Segment President. John Barger will be promoted from President of Medicaid and Dual Eligible programs to President of Medicare Advantage, reporting to Martin.

What will Renaudin be paid during the transition?

During the advisory period through December 31, 2026, he continues to receive his current base salary, annual incentive opportunity and benefits. During the VSP period through March 1, 2027, he receives no salary, only an hourly rate for work performed, and continued equity vesting under the stock incentive plan.

Is Humana changing its 2025 earnings outlook?

Humana reaffirmed FY 2025 guidance of approximately $12.26 diluted GAAP EPS and approximately $17.00 Adjusted EPS. It does not expect changes to Adjusted EPS guidance but may see changes to GAAP EPS guidance due to ongoing value creation and strategic initiatives.

What conditions apply to Renaudin's severance?

At the end of the VSP period, he will receive benefits under Section 3 of the Company's Executive Severance Policy, subject to executing a general release of claims and complying with applicable non-compete and non-solicit covenants.

HUM 8-K: Leadership Changes & Regulation FD

01—Abstract

Summary

Summary of the 8-K filed December 16, 2025. Cited figures are marked; the original filing is the authoritative source.

Humana Inc. (NYSE: HUM) announced on December 16, 2025 a leadership transition in its Insurance segment.

George Renaudin, Insurance Segment President and member of the Enterprise Leadership Team, will retire by the third quarter of 2026 after a 29-year career. He will serve as a strategic advisor through December 31, 2026, then move to the variable staffing pool (temporary worker status) until March 1, 2027. During the advisory period he keeps his current base salary, annual incentive opportunity and benefits; during the VSP period he receives no salary, only an hourly rate for work performed, plus continued equity vesting.

At the end of the VSP period, and subject to a general release and non-compete and non-solicit compliance, he will receive benefits under Section 3 of the Company's Executive Severance Policy. Aaron Martin will join in January 2026 as President of Medicare Advantage, a newly created role reporting jointly to Renaudin and CEO Jim Rechtin. After Renaudin's transition, Martin becomes Insurance Segment President, and John Barger, currently President of the Medicaid and Dual Eligible programs, will be promoted to President of Medicare Advantage, reporting to Martin.

Martin previously served as Vice President of Healthcare at Amazon and as Executive Vice President and Chief Digital Officer at Providence. In a separate Regulation FD disclosure, Humana reaffirmed its FY 2025 guidance of approximately $12.26^a diluted GAAP EPS and approximately $17.00 Adjusted (non-GAAP) EPS, consistent with its November 5, 2025 press release and December 1, 2025 Form 8-K. The company stated it does not expect changes to Adjusted EPS guidance but may see changes to GAAP EPS guidance from ongoing value creation and strategic initiatives.

02—Key points

Key Highlights

George Renaudin, Insurance Segment President, will retire by Q3 2026 after 29 years; he will serve as a strategic advisor through December 31, 2026, then in the VSP until March 1, 2027.
Aaron Martin joins in January 2026 as the newly created President of Medicare Advantage and becomes Insurance Segment President after Renaudin's transition.
John Barger, currently President of Medicaid and Dual Eligible programs, will be promoted to President of Medicare Advantage, reporting to Martin.
Renaudin's advisory compensation continues his base salary, annual incentive opportunity and benefits; during the VSP period he receives only an hourly rate, with continued equity vesting.
Renaudin's end-of-service severance benefits under Section 3 of the Executive Severance Policy are conditioned on a general release and non-compete and non-solicit compliance.
Humana reaffirmed FY 2025 guidance of approximately $12.26 diluted GAAP EPS and approximately $17.00 Adjusted EPS.
The company does not expect changes to Adjusted EPS guidance but expects potential changes to GAAP EPS guidance from ongoing value creation initiatives.

03—Questions

Frequently Asked Questions

Who is leaving, and when?
George Renaudin, Insurance Segment President and member of the Enterprise Leadership Team, will retire by the third quarter of 2026 after a 29-year career at Humana.
Who replaces Renaudin and what roles are changing?
Aaron Martin joins in January 2026 as President of Medicare Advantage and, after Renaudin's transition, becomes Insurance Segment President. John Barger will be promoted from President of Medicaid and Dual Eligible programs to President of Medicare Advantage, reporting to Martin.
What will Renaudin be paid during the transition?
During the advisory period through December 31, 2026, he continues to receive his current base salary, annual incentive opportunity and benefits. During the VSP period through March 1, 2027, he receives no salary, only an hourly rate for work performed, and continued equity vesting under the stock incentive plan.
Is Humana changing its 2025 earnings outlook?
Humana reaffirmed FY 2025 guidance of approximately $12.26 diluted GAAP EPS and approximately $17.00 Adjusted EPS. It does not expect changes to Adjusted EPS guidance but may see changes to GAAP EPS guidance due to ongoing value creation and strategic initiatives.
What conditions apply to Renaudin's severance?
At the end of the VSP period, he will receive benefits under Section 3 of the Company's Executive Severance Policy, subject to executing a general release of claims and complying with applicable non-compete and non-solicit covenants.

04—Continue

← View all 8-K filings